Vertex Pharmaceuticals Inc 10-K for FY2022
Vertex Pharmaceuticals Inc (VRTX)
10-K
2023-02-10
For: 2022-12-31
View Original
Added on
April 02, 2026
About this 10-K
Vertex Pharmaceuticals Inc filed this 10-K on February 10, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $8.93B
- up 17.9% from $7.57B a year earlier
- Net income
- $3.32B
- up 41.8% from net income of $2.34B a year earlier
- Diluted EPS
- $12.82
- up 42.3% from $9.01 a year earlier